Scynexis Ownership
| SCYX Stock | USD 0.73 0.01 1.35% |
Shares in Circulation | First Issued 2013-03-31 | Previous Quarter 38 M | Current Value 49.4 M | Avarage Shares Outstanding 16.5 M | Quarterly Volatility 18.9 M |
Scynexis Stock Ownership Analysis
About 30.0% of the company shares are owned by institutional investors. The company has price-to-book ratio of 0.59. Typically companies with comparable Price to Book (P/B) are able to outperform the market in the long run. Scynexis recorded a loss per share of 0.56. The entity last dividend was issued on the 17th of July 2020. The firm had 1:10 split on the 17th of July 2020. SCYNEXIS, Inc., a biotechnology company, develops products for the treatment fungal infections in the United States. SCYNEXIS, Inc. was incorporated in 1999 and is headquartered in Jersey City, New Jersey. Scynexis operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on NASDAQ Exchange. It employs 56 people. To find out more about Scynexis contact Marco MD at 201 884 5485 or learn more at https://www.scynexis.com.Scynexis Stock Institutional Investors
Have you ever been surprised when a price of an equity instrument such as Scynexis is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Scynexis backward and forwards among themselves. Scynexis' institutional investor refers to the entity that pools money to purchase Scynexis' securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
| Shares | Northern Trust Corp | 2025-03-31 | 137.6 K | State Street Corp | 2025-03-31 | 120.7 K | Empowered Funds, Llc | 2025-03-31 | 107.3 K | Wealth Effects Llc | 2025-03-31 | 89.5 K | Nierenberg Investment Management Co | 2025-03-31 | 75.6 K | Citadel Advisors Llc | 2025-03-31 | 72.4 K | Ubs Group Ag | 2025-03-31 | 68.9 K | Lpl Financial Corp | 2025-03-31 | 62.9 K | Squarepoint Ops Llc | 2025-03-31 | 37.1 K | Federated Hermes Inc | 2025-03-31 | 2.9 M | Kingdon Capital Management Llc | 2025-03-31 | 2.2 M |
Scynexis Insider Trading Activities
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Scynexis insiders, such as employees or executives, is commonly permitted as long as it does not rely on Scynexis' material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Scynexis insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Scynexis Outstanding Bonds
Scynexis issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Scynexis uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Scynexis bonds can be classified according to their maturity, which is the date when Scynexis has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| MPLX LP 4125 Corp BondUS55336VAK61 | View | |
| MPLX LP 52 Corp BondUS55336VAL45 | View | |
| BNP Paribas FRN Corp BondUSF1R15XK367 | View | |
| Morgan Stanley 3971 Corp BondUS61744YAL20 | View | |
| MGM Resorts International Corp BondUS552953CD18 | View | |
| Valero Energy Partners Corp BondUS91914JAA07 | View |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Scynexis Stock Analysis
When running Scynexis' price analysis, check to measure Scynexis' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Scynexis is operating at the current time. Most of Scynexis' value examination focuses on studying past and present price action to predict the probability of Scynexis' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Scynexis' price. Additionally, you may evaluate how the addition of Scynexis to your portfolios can decrease your overall portfolio volatility.